is tirzepatide still on the fda shortage list backtracks over Eli Lilly weight-loss drug Compounders protest as FDA removes
Description
In some cases, it may even lead to confusion or impaired thinking

doi: 10.1210/jc.2018-01008

Unintended weight loss

Indications Diagnostic Meningitis CSF culture and analysis Encephalitis Subarachnoid hemorrhage (xanthochromia detection) Multiple sclerosis oligoclonal bands Increased intracranial pressure (sometimes, but check first!) Therapeutic Administer intrathecal drugs Reduce CSF pressure in certain conditions Contraindications Increased intracranial pressure due to mass lesion (risk of brain herniation) Infection at puncture site Coagulopathy / bleeding disorders Severe spinal deformity Procedure 1

Clinical evidence shows modest effects on weight loss
Sleep quality can be affected by both the autoimmune condition and, at higher doses, by GLP-1 therapy itself
